LFST - NASDAQ
LifeStance Health Group, Inc.
$7.50
-5.5%LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
At a Glance
Live SnapshotLifeStance Health Group, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Strong liquidity. The company has adequate resources to meet short-term liabilities.
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Financial Health Insight
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
LifeStance Health Group, Inc. Balance Sheet
LFST • NASDAQ
| LifeStance Health Group, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
ASSETS | |||||||
CURRENT ASSETS | |||||||
248.6M | 154.6M | 78.8M | 108.6M | 148M | 18.8M | 3.5M | |
248.6M | 154.6M | 78.8M | 108.6M | 148M | 18.8M | 3.5M | |
95.7M | 132M | 125.6M | 101.5M | 99.3M | 43.7M | 19.1M | |
95.7M | 131.8M | 125.4M | 100.9M | 76.1M | 43.7M | 18.6M | |
0.0 | 223K | 235K | 640K | 23.2M | 0.0 | 497K | |
0.0 | 0.0 | 0.0 | 0.0 | 38.1M | 0.0 | 0.0 | |
0.0 | 11M | 10.5M | 12.1M | 6.8M | 5.9M | 4.8M | |
71.8M | 14.9M | 10.7M | 11M | -25.7M | 7.8M | 0.0 | |
416.2M | 312.5M | 225.7M | 233.2M | 266.5M | 76.3M | 27.4M | |
NON-CURRENT ASSETS | |||||||
311.3M | 313.9M | 358.9M | 393.6M | 152.2M | 59.3M | 22.4M | |
1.3B | 1.3B | 1.3B | 1.3B | 1.2B | 1.1B | 214.6M | |
177.7M | 190.8M | 221.1M | 263.3M | 300.4M | 332.8M | 15M | |
1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.4B | 229.6M | |
0.0 | 0.0 | 0.0 | 0.0 | -42.6M | -10.8M | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 42.6M | 10.8M | 0.0 | |
5.4M | 7.7M | 10.9M | 10.8M | 3.4M | 2.6M | 1.4M | |
1.8B | 1.8B | 1.9B | 1.9B | 1.7B | 1.5B | 253.4M | |
2.2B | 2.1B | 2.1B | 2.2B | 1.9B | 1.6B | 280.8M | |
LIABILITIES | |||||||
CURRENT LIABILITIES | |||||||
6.1M | 7.2M | 23.2M | 24.4M | 14.2M | 7.7M | 8.5M | |
6.1M | 7.2M | 23.2M | 24.4M | 14.2M | 7.7M | 8.3M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 191K | |
0.0 | 146M | 121.3M | 94M | 76.1M | 45.2M | 23.4M | |
45.5M | 7.3M | 2.9M | 2.3M | 1.3M | 3.7M | 0.0 | |
0.0 | 49.4M | 46.5M | 38.8M | 0.0 | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 446K | 191K | |
0.0 | 0.0 | 0.0 | 0.0 | 76.1M | 0.0 | 0.0 | |
200.3M | 19M | 8.9M | 16.5M | -50.8M | 19.2M | 23.2M | |
252M | 228.9M | 202.9M | 176M | 116.8M | 75.9M | 55M | |
NON-CURRENT LIABILITIES | |||||||
148.6M | 279.8M | 280.3M | 225.1M | 157.4M | 362.5M | 79.3M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35M | 0.0 | |
16.4M | 14.3M | 15.6M | 38.7M | 54.3M | 81.2M | 863K | |
266M | 309K | 952K | 2.8M | 53.6M | 17.2M | 312M | |
431M | 443.1M | 478.2M | 479.1M | 265.3M | 496M | 392.1M | |
0.0 | 198.1M | 227.8M | 251.4M | 0.0 | 0.0 | 0.0 | |
682.9M | 672M | 681M | 655.1M | 382.1M | 571.9M | 447.1M | |
SHAREHOLDERS' EQUITY | |||||||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35M | 0.0 | |
3.9M | 3.8M | 3.8M | 3.8M | 3.7M | 1B | 3K | |
0.0 | 2.3B | 2.2B | 2.1B | 1.9B | 1.5M | 0.0 | |
-808.6M | -818.3M | -760.8M | -572.6M | -357.1M | -13.1M | -166.4M | |
0.0 | 929K | 2.3M | 3.3M | 0.0 | -35M | 0.0 | |
2.3B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
1.5B | 1.4B | 1.4B | 1.5B | 1.5B | 997.8M | -166.4M | |
1.5B | 1.4B | 1.4B | 1.5B | 1.5B | 997.8M | -166.4M | |
SUMMARY | |||||||
2.2B | 2.1B | 2.1B | 2.2B | 1.9B | 1.6B | 280.8M | |
0.0 | 0.0 | 0.0 | 0.0 | -42.6M | -10.8M | 0.0 | |
194.1M | 485.2M | 511M | 478.8M | 158.7M | 366.3M | 79.3M | |
-54.5M | 330.6M | 432.2M | 370.2M | 10.7M | 347.4M | 75.8M | |
389,000,000 | 389,000,000 | 389,000,000 | 389,000,000 | 389,000,000 | 389,000,000 | 389,000,000 |
SEC Filings
LFST - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 11, 2026 | March 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | February 25, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 |
Related Guides
Continue your LFST research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.